Datatrak receives $8m from TabaFund to advance eClinical solutions

By Maggie Lynch

- Last updated on GMT

The $8m from its long-term investor TabaFund will be used to expand Datatrak’s sales and e-clinical technologies for the clinical research industry.

Datatrak International is a software-as-a-Service (SaaS) provider of cloud-based technology used by clinical research companies. Its Enterprise Cloud has been deployed across 83 countries and more than 63,000 users. The eClinical platform is a single login, multi-tenant, and multi-lingual SaaS offering designed to execute and manage clinical trials that receive data from devices, patients, sites, and labs.

“TabaFund had a choice of investing its money into any of the eClinical companies, and the decision to invest our money into Datatrak is obvious when you review the competitive landscape and their respective technology,” ​said Alex Tabatabai, chief investment officer of TabaFund in a press release.

According to Datatrak, the global industry for eClinical companies had seen 10% annual growth over 15 years, with future expected growth. This growth has created an opportunity for additional investments to expand sales and fund product development and marketing.

The company plans to continue expanding its Cloud Enterprise platform into business analysis and predictive analytics (BI) across laboratory images, ECGs and patient direct assessments and diaries (ePRO), wearable devices (eCOA), and through informed consent (eConsent).

Expected delivery of “patient direct solutions” is slated for this year with further additions in 2019, according to Datatrak.

“As we look across the mobile health landscape and talk with our customers, we are gaining intelligence to better understand customer pain-points and deficits of other systems while keying in on areas where we can address those frustrations,” ​said Tim Lyons, vice president of product development and operations at Datatrak.

The private investment fund TabaFund previously invested in Datatrak, leading the proxy campaign to change the previous management in 2015 and invested $1.5m the following year.

“Now, TabaFund is doubling down to fuel our growth and platform expansion plans,”​ said Datatrak CEO Jim Bob Ward.

Neither Datatrak nor TabaFund were available for comment

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more